Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Neovasc Inc (NVCN)

  7. Neovasc Inc (NVCN) News

NVCN

Neovasc Inc

30.03
0.00 (0.0%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
Neovasc Inc NVCN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.00 0.0% 30.03 20:00:00
Open Price Low Price High Price Close Price Prev Close
30.03 30.03
more quote information »

Recent News

Date Time Source Heading
4/24/202316:15EDGARNotice of Termination of a Foreign Private Issuer's..
4/12/202313:11EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/11/202309:19EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/11/202309:11EDGARWithdrawal of Registration Statement (rw)
4/11/202309:08EDGARPost-effective Amendment to Registration Statement for..
4/11/202309:07EDGARPost-effective Amendment to Registration Statement (pos Am)
4/11/202309:06EDGARPost-effective Amendment to an S-8 Filing (s-8 Pos)
4/11/202308:48EDGARNotification Filed by National Security Exchange to Report..
4/11/202308:21EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/11/202308:20GLOBEShockwave Medical Completes Acquisition of Neovasc
3/31/202316:11GLOBENeovasc Announces Fourth Quarter and Fiscal Year 2022..
3/09/202316:26EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/07/202306:09EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/06/202317:37GLOBENeovasc Shareholders Approve Acquisition by Shockwave..
2/10/202316:08EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/01/202309:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/01/202309:05GLOBENeovasc Announces German Reimbursement Renewal
1/27/202316:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/17/202309:29EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/17/202308:00GLOBEShockwave Medical to Acquire Neovasc
11/28/202216:45GLOBENeovasc Announces Progress on COSIRA-II Clinical Trial
11/18/202209:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/18/202209:05GLOBENeovasc Comments on European Heart Journal Publication
11/15/202206:45TRMNH.C. Wainwright Sticks to Its Buy Rating for Neovasc (NVCN)
11/10/202216:08EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/10/202216:05GLOBENeovasc Announces Third Quarter Financial Results and..
11/08/202209:05GLOBENeovasc Reducer Obtains U.S. Outpatient Reimbursement
10/27/202209:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
10/27/202209:00GLOBENeovasc to Report Third Quarter Financial Results on..
9/20/202209:08EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/20/202209:05GLOBENeovasc Provides Corporate Update Following Clinical Data..
9/16/202209:25EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/16/202209:00GLOBENeovasc to Participate in LSI Europe 2022 Emerging MedTech..
9/15/202209:09EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/15/202209:05GLOBENeovasc Comments on New ICD-10-CM Diagnosis Codes for..
9/08/202209:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/08/202209:05GLOBENeovasc Announces Key Events at TCT 2022
8/30/202209:09EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/30/202209:05GLOBENeovasc to Participate in H.C. Wainwright 24th Annual Global..
8/22/202206:20TRMNAnalysts Offer Insights on Healthcare Companies: Freeline..
8/11/202216:07EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/11/202216:05GLOBENeovasc Announces Second Quarter Financial Results and..
7/28/202209:00GLOBENeovasc to Report Second Quarter Financial Results on August..
7/26/202209:15EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/26/202209:05GLOBENeovasc Announces FDA Approval of Planned COSIRA II..
7/05/202209:05GLOBENeovasc Announces Direct Sales Operations in United Kingdom
6/08/202209:19EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/08/202209:05GLOBENeovasc to Participate in Sidoti & Co. Summer Small Cap..